The United States will remain the world’s largest medical aesthetic device market for at least a few more years, but demand is increasing faster in emerging economies, according to a recent report from BCC Research.

In 2015, the U.S. market for aesthetic and cosmetic devices is expected to hit almost $1.4 billion, although growth here will slow to 3.7% year over year until then. By contrast, the Chinese and Brazilian markets are predicted to expand at nearly four times that rate, reaching $696 million and $572 million, respectively.

“For medical device manufacturers, the takeaway is to focus on increasing their sales presence in China and Brazil,” says Richard Rahn, a market research analyst for BCC Research. “The target population (middle- and upper-income women) and total sales will more than double in these countries over the next five years.”

The report also cites significant markets such as India, where the number of women able to afford cosmetic procedures is expected to almost double, and Mexico, where the target demographic will grow by nearly half.

In Europe, where Rahn says the stigma associated with cosmetic procedures is fading, the market will surpass $1 billion on a compound annual growth rate of 8.9%. In Japan, on the other hand, an aging population is expected to drive down demand for the devices, shrinking the market by around $29 million.

Worldwide, the medical aesthetic device market is expected to grow by 7.4% year over year, reaching $4.8 billion in 2015.

Of the devices detailed in the report— including botulinum neuromodulators, breast augmentation devices, devices for assisted liposuction, and externally-applied energy-emitting devices for a variety of cosmetic applications—injectable dermal fillers (specifically hyaluronic acid) will experience the most growth, Rahn says.

—Jamie Hartford